BIOACTIVE PEPTIDE MARKET ANALYSIS

Bioactive Peptide MarketSize and Trends

Global bioactive peptide market is estimated to be valued at US$ 4,960.4 million in 2022 and is expected to exhibit a CAGR of 9.4% during the forecast period (2022-2030).

Figure 1. Global Bioactive Peptide Market Share (%), by Source, 2022

Increasing preference of plant based collagen peptide and plant based alternatives for egg and seafood is expected to drive growth of the global bioactive peptide market over the forecast period.

Increasing preference and use of plant collagen peptide is expected to drive growth of the global bioactive peptide market over the forecast period. For instance, on June 29, 2022, Vital Proteins, manufactures of  health supplement Product Company, announced the launch of Vital Proteins Lemon Collagen Peptides, containing grass-fed, pasture-raised collagen with an added boost of lemon flavor.

Moreover, in October 2021, Nestle, a food company, announced the launch of plant based alternatives for egg and shrimp (Seafood). The egg alternative was launched under Garden Gourmet vEGGie, the product was vegan, contains soy protein and omega-3 fatty, whereas Nestle expanded its plant-based seafood offerings with the Garden Gourmet Vrimp, which was vegan and made from a combination of seaweed, peas and konjac root.

Figure 2. Global Bioactive Peptide Market Share (%), by Region, 2022

Increasing number of inorganic strategies such as product launch by key players in market is expected to drive growth of the global bioactive peptide market over the forecast period.

Increasing number of inorganic strategies such as product launch by market players is expected to boost the global bioactive peptide market growth over the forecast period. For instance, In November 2018, Nuritas Ltd., a biotechnology company, announced the commercial launch of Peptide which contained anti-inflammatory bioactive peptides. It was the first bioactive ingredient discovered and delivered through artificial intelligence.

Furthermore, in October 2020, Hofseth Biocare, a biotechnology company, announced the launch of ProGo bioactive peptides in the U.S., which helps maintain iron-rich blood, promotes energy utilization, supports red blood cell production, supports gastrointestinal and immune system health and assists in iron absorption from daily diet.

Global Bioactive Peptide Market: Key Developments